Supplemental Experimental Procedures

Transgenic constructs
Point mutations and ETS site mutations were made using a QuickChangeII XL site directed mutagenesis kit (Stratagene) while the +Ts and +ETS inserts were generated by PCR. In all cases, the entire ZRS insert was sequenced before use.
The oligonucleotides used in the mutagenesis are listed below-- Nuclear extracts used in the EMSA were prepared from limb tissue using a NE-PER nuclear and cytoplasmic extraction kit (Thermo Scientific).The autopods of fore and hindlimb of E11.5 embryos were removed and either used whole or further dissected into anterior and posterior halves.
Mutagenesis
EMSA reactions were separated on a pre-run 6% native polyacrylamide gel for 1 hour at 100V, 4 C. Reactions were made up in a total volume of 15 l with 1.5 l 10X EMSA buffer (10mM Tris-Hcl pH7.9, 50mM KCl and 1mM DTT), 1 l of poly dI/dC (Sigma) (1mg/ml) and 6 g of nuclear extract. Samples were incubated for 5 minutes on ice before 20 fmol biotin-labelled probe (oligos end labelled with biotin were purchased from Sigma and annealed) was added and reactions incubated at RT for 20 minutes before loading dye was added and loaded. For depletions, anti-ETS1, anti-GABP , anti ETS2, anti ELF-1, anti-ETV4 and anti-ETV5 or purified IgG.
as a control was added along with nuclear extract and incubated for 10 minutes at room temperature prior to addition of the probe. For competition assays, unlabelled probes were added with nuclear extract prior to incubation with the labelled probe.
Oligonucleotide pairs used for the EMSA analysis are listed below-
